|
The document is a final report from 3M Company detailing a longitudinal analysis of serum levels of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) in relation to lipid and hepatic clinical chemistry test results among male employees participating in the company's fluorochemical medical surveillance program conducted in 1994/95, 1997, and
|
2001 |
AR226-1088
|
xzxzyDB05Xvq233yprqbaYpKE |
63 |